Wells Fargo & Company Boston Scientific Corp Call Options Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022
SELL
$40.9 - $45.1 $1.07 Million - $1.18 Million
-26,100 Reduced 68.68%
11,900 $527,000
Q3 2020

Nov 05, 2020
SELL
$34.44 - $42.23 $21.9 Million - $26.9 Million
-637,000 Reduced 94.37%
38,000 $1,000
Q2 2020

Aug 13, 2020
BUY
$30.19 - $39.11 $20.4 Million - $26.4 Million
675,000 New
675,000 $291,000

Others Institutions Holding BSX

# of Institutions
1,450
Shares Held
1.21B
Call Options Held
8.14M
Put Options Held
8.3M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email